Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01691430 · ClinicalTrials.gov registry record · Phase 3
A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents
A Phase 3 study of Bacteriuria, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 185
- Enrollment target
- 20
- Study locations
NCT01691430: Completed Phase 3 study of Bacteriuria, sponsored by Yale University.
NCT01691430 is a Phase 3 study of Bacteriuria that has completed, run by Yale University. The registered enrollment target is 185 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% lower). The trial reports 20 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01691430, a Phase 3 study of Bacteriuria, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 185 participants
- Enrollment target
- 20
- Study locations
Study Summary
Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacteriuria plus pyuria in female nursing home residents. These aims will be accomplished by conducting a double blind randomized placebo controlled efficacy trial of two oral cranberry capsules daily versus placebo in a cohort of Connecticut female nursing home residents.
Primary Outcome
Clean catch urine cultures and urinalyses will be obtained every two months for each participant for study purposes.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 2 cranberry capsules
Study Locations (20)
Connecticut
- Branford Hills Health Care - Branford
- Northbridge Health Care Center - Bridgeport
- Bridgeport Health Care Center - Bridgeport
- Bridgeport Manor - Bridgeport
- Riverside Health & Rehabilitation Center - East Hartford
- Ludlowe Health Care Center - Fairfield
- Glastonbury Health Care Center - Glastonbury
- The Nathaniel Witherell - Greenwich
- Arden House Care and Rehabilitation Center - Hamden
- Hamden Health Care Center - Hamden
- Avery Heights - Hartford
- Wadsworth Glen Health Care and Rehabilitation Center - Middletown
- Water's Edge Center for Health & Rehabilitation - Middletown
- Grimes Center - New Haven
- Mary Wade Home - New Haven
- Advanced Nursing & Rehab Center of New Haven - New Haven
- Shady Knoll Health Center - Seymour
- Lord Chamberlain Nursing & Rehabilitation Center - Stratford
- Village Green of Wallingford - Wallingford
- Abbott Terrace Health Center - Waterbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 185 participants |
| Start Date | 2012-08 |
| Est. Completion | 2015-10 |
| Phase | Phase 3 |
What the finished NCT01691430 record still lists
NCT01691430 is an interventional study that assigns participants to a tested intervention. The registered 185 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (76% lower).
The record links to 1 condition, with Bacteriuria appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01691430 names 20 study sites across 1 states, led by Connecticut.
Frequently Asked Questions
What is clinical trial NCT01691430 about?
NCT01691430 is a clinical study titled "A Trial of Cranberry Capsules for Urinary Tract Infection Prevention in Nursing Home Residents". Urinary tract infection (UTI) is the most common infection in nursing home residents, and bacteriuria is the greatest trigger for antimicrobial therapy in the nursing home setting. The primary aim of this study is to test the efficacy of two oral cranberry capsules per day in the reduction of bacter...
What is the current status of trial NCT01691430?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 185 participants. The study started on 2012-08. Estimated completion is 2015-10.
What conditions does trial NCT01691430 study?
This clinical trial studies the following conditions: Bacteriuria.
What interventions are being tested in trial NCT01691430?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 2 cranberry capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01691430?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01691430 being conducted?
This trial has 20 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteriuria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01691430's enrollment target sits among peer trials
185 1417th of 2000 higher than 583 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04041154 · 185 participants · NA
Behavioral and Neural Representations of Subjective Effort Cost
- NCT04484272 · 185 participants · NA
A Stress and Pain Self-management m-Health App for Adult Outpatients With Sickle Cell Disease
- NCT05020860 · 185 participants · Phase 2
Correlation of Clinical Response to Pathologic Response in Patients With Early Breast Cancer
- NCT05793541 · 185 participants · NA
Just-in-time Interventions for Reducing Short-term Suicide Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia